Jiangsu Hansoh Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ICATIBANT ACETATE, with a corresponding US DMF Number 31106.
Remarkably, this DMF maintains an Active status since its submission on December 16, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 19, 2017, and payment made on November 14, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II